Today: 7 February 2026
Subscribe

Academy Sports and Outdoors Stock (ASO) Drops on Dec. 22, 2025: Nike Shockwaves, Q3 Results, Updated Guidance, Analyst Price Targets, and 2026 Forecasts

Academy Sports and Outdoors Stock (ASO) Drops on Dec. 22, 2025: Nike Shockwaves, Q3 Results, Updated Guidance, Analyst Price Targets, and 2026 Forecasts

Academy Sports and Outdoors, Inc. (NASDAQ: ASO) stock traded lower on Monday, December 22, 2025, as a mix of sector headlines and company-specific fundamentals collided—again reminding investors that retail is where macro nerves go to get amplified. As of the latest available trading data, ASO was around $51.21, down about 4.64% on the day, with a market cap near $3.45 billion. The down move comes even though Academy’s most recent quarterly report showed improving profitability and a narrowed full-year outlook. So what’s driving the weakness today, what do the latest forecasts say, and how is Wall Street positioning into 2026?
22 December 2025
······
Via Transportation (VIA) Stock News Today: Russell 2000 Addition, Downtowner Deal, and Short-Seller Claims Fuel Volatility (Dec. 22, 2025)

Via Transportation (VIA) Stock News Today: Russell 2000 Addition, Downtowner Deal, and Short-Seller Claims Fuel Volatility (Dec. 22, 2025)

Via Transportation, Inc. (NYSE: VIA) is back in the market spotlight on Dec. 22, 2025—less because of a single headline and more because several “stock-moving forces” are colliding at once: index inclusion, fresh M&A, and a high-profile short report debating whether Via is really a software platform or a lower-margin transit operator. As of the latest available trading data today, VIA shares were around $30.70, down about $2.60 from the prior close—roughly a 7.8% decline—after trading in a wide intraday range (high near the mid-$34s, low around $30.70). *(Quick ticker hygiene note: this article is about Via Transportation (NYSE: VIA),
22 December 2025
·····
Gilead Sciences (GILD) Stock News Today: New Herpes Deal, TrumpRx Pricing Pact, and Fresh Wall Street Forecasts (Dec. 22, 2025)

Gilead Sciences (GILD) Stock News Today: New Herpes Deal, TrumpRx Pricing Pact, and Fresh Wall Street Forecasts (Dec. 22, 2025)

Gilead Sciences, Inc. (NASDAQ: GILD) opened the holiday-shortened week with a mix of pipeline expansion and policy-driven uncertainty—two themes that can quickly move large-cap biopharma stocks even when overall market volume is lighter than usual. On Monday, December 22, 2025, Gilead announced it has exercised its option to license Assembly Biosciences’ investigational herpes simplex virus (HSV) programs—a move that strengthens Gilead’s long-term antiviral pipeline beyond HIV. The development lands just days after Gilead joined other major drugmakers in a Trump administration “most-favored-nation” drug-pricing agreement tied to tariff relief and direct-to-consumer drug access via TrumpRx.gov. Gilead+2Gilead+2 As of the latest available
22 December 2025
·····
Dillard’s Stock (DDS) Drops on Dec. 22, 2025: Today’s News, Special Dividend Details, and Wall Street Forecasts

Dillard’s Stock (DDS) Drops on Dec. 22, 2025: Today’s News, Special Dividend Details, and Wall Street Forecasts

December 22, 2025 — Dillard’s, Inc. (NYSE: DDS) is back in the spotlight after a sharp selloff on Monday, adding fresh volatility to what’s been a remarkably strong year for one of America’s last major publicly traded department-store chains. Shares were last indicated around $610, down roughly 8% on the day after trading as high as the upper-$660s and as low as the low-$600s. The move lands at an awkward moment for investors: Dillard’s has paired steady operating performance with aggressive shareholder returns (including a $30 special dividend), but multiple research notes and data providers continue to flag valuation risk
22 December 2025
·····
Intuit Stock (INTU) Today: Stablecoin Push With Circle, OpenAI Deal, and 2026 Tax Season Catalysts Investors Are Watching

Intuit Stock (INTU) Today: Stablecoin Push With Circle, OpenAI Deal, and 2026 Tax Season Catalysts Investors Are Watching

Intuit Inc. (NASDAQ: INTU) heads into the final stretch of 2025 with multiple narrative “tailwinds” converging at once: a new stablecoin partnership aimed at speeding up money movement, a major AI tie-up with OpenAI, and fresh TurboTax/Credit Karma marketing initiatives designed to pull more consumers into its broader financial ecosystem. As of Monday, December 22, 2025, Intuit shares traded at $675.71, up about 0.65% on the session, with an intraday range of $671.50–$679.26. Below is what’s driving the story now, the forecasts that matter into early 2026, and the key risks investors should keep on the radar. What’s moving Intuit
22 December 2025
····
Kohl’s Stock (NYSE: KSS) Drops on Dec. 22, 2025: Short Interest Climbs, Analyst Targets Lag After a Volatile 2025 Rally

Kohl’s Stock (NYSE: KSS) Drops on Dec. 22, 2025: Short Interest Climbs, Analyst Targets Lag After a Volatile 2025 Rally

Kohl’s Corporation stock (NYSE: KSS) sold off sharply in Monday trading on December 22, 2025, underscoring just how jumpy this name remains after a meme-stock-flavored year. By early afternoon, KSS traded around $21.6, down roughly 7% on the session, after opening near $23.20 and touching an intraday low around $21.69. Volume was a little over 2.2 million shares at the time of the quote—active, but not the kind of panic stampede you’d see in a full-blown capitulation day. StockAnalysis+1 If you’re trying to make sense of Kohl’s stock right now, the market’s “story stack” is basically three layers deep: Here’s
22 December 2025
·····
Dominion Energy Stock Drops on Offshore Wind Lease Pause: What Investors Should Know About NYSE:D, CVOW, Dividends and the 2026 Outlook

Dominion Energy Stock Drops on Offshore Wind Lease Pause: What Investors Should Know About NYSE:D, CVOW, Dividends and the 2026 Outlook

Dominion Energy, Inc. (NYSE: D) stock took an uncharacteristically sharp hit on December 22, 2025, sliding roughly 5%–6% into the mid‑$50s as Washington put the brakes on the U.S. offshore wind buildout—right in the middle of construction. Reuters+1 Utilities usually trade like slow-moving planets: predictable gravity, modest drama. Today was different. The reason wasn’t earnings, a dividend cut, or a surprise rate case loss. It was policy risk colliding with a $11-ish billion megaproject that Dominion has positioned as a cornerstone of Virginia’s energy future. Below is what happened, what the key headlines and analysts are saying as of 22.12.2025,
22 December 2025
·····
Boeing Stock News Today (Dec. 22, 2025): BA Price Action, Fresh Headlines, Analyst Forecasts, and the 2026 Outlook

Boeing Stock News Today (Dec. 22, 2025): BA Price Action, Fresh Headlines, Analyst Forecasts, and the 2026 Outlook

Boeing Company (The) (NYSE: BA) is back in the spotlight on Monday, December 22, 2025, as investors balance encouraging signals on production discipline and supplier quality with persistent regulatory and headline risk. BA stock was last trading around $216.39, up about 1.1% on the day, after ranging roughly between $214.22 and $217.09. Boeing stock price today: where BA stands on Dec. 22, 2025 Boeing shares are edging higher into late December after a strong stretch of momentum that’s kept the stock in “recovery trade” territory—driven less by near-term earnings power and more by confidence that production stability can translate into
22 December 2025
·····
Infosys Stock (INFY) Jumps After ADR Whiplash and McCamish Settlement Update: Latest News, Forecasts, and What’s Next (Dec. 22, 2025)

Infosys Stock (INFY) Jumps After ADR Whiplash and McCamish Settlement Update: Latest News, Forecasts, and What’s Next (Dec. 22, 2025)

Infosys Limited (NSE: INFY; BSE: INFY; NYSE: INFY) is back in the spotlight on December 22, 2025—this time for a rare mix of market microstructure drama and a legal overhang getting clearer. India-listed Infosys shares rose in Monday trading after the company addressed an unusual surge in its U.S.-traded American Depositary Receipts (ADRs) and investors digested a court update tied to its U.S. subsidiary, Infosys McCamish Systems. Reuters+2Infosys+2 The immediate trigger for Monday’s move was the aftershock of Friday’s ADR spike on the New York Stock Exchange (NYSE), where Infosys said volatility in the ADR price resulted in two volatility
22 December 2025
······
Chevron Stock (CVX) Climbs on Venezuela Supply Risks: Latest News, Forecasts and Outlook (Dec. 22, 2025)

Chevron Stock (CVX) Climbs on Venezuela Supply Risks: Latest News, Forecasts and Outlook (Dec. 22, 2025)

Chevron Corporation’s stock was higher Monday as a fresh wave of Venezuela-related shipping headlines pushed oil prices up and put energy names back in focus during a holiday-shortened week. As of midday Monday, Chevron (NYSE: CVX) traded around $150, up roughly 1.6% on the session. MarketWatch reported Chevron was also a notable driver of the Dow’s intraday gain, reflecting the stock’s outsized influence inside the price-weighted index. MarketWatch Below is what’s moving Chevron today, what analysts and markets are watching next, and how the company’s capital-return and spending plans frame the longer-term bull and bear cases for CVX. Why Chevron
22 December 2025
····
Edgewise Therapeutics (EWTX) Stock News Today: What’s Driving the Volatility, Analyst Forecasts, and Key Catalysts (Dec. 22, 2025)

Edgewise Therapeutics (EWTX) Stock News Today: What’s Driving the Volatility, Analyst Forecasts, and Key Catalysts (Dec. 22, 2025)

December 22, 2025 — Edgewise Therapeutics, Inc. (NASDAQ: EWTX) is back in the spotlight as its stock price whipsaws following a sharp late-week surge and a fresh round of market commentary that mixes optimism about the company’s muscle-disease pipeline with familiar concerns about cash burn in a pre-revenue biotech. As of 18:40 UTC on Dec. 22, EWTX traded at $21.29, after swinging between $27.77 and $21.18 intraday, with volume running well above a million shares. Below is a complete, news-style breakdown of the current coverage and forecasts circulating on Dec. 22, 2025, plus the trial and business milestones investors are
22 December 2025
·····
Insmed (INSM) Stock News Today: Nasdaq‑100 Addition, Brensocatib Setback, and Updated Analyst Forecasts (Dec. 22, 2025)

Insmed (INSM) Stock News Today: Nasdaq‑100 Addition, Brensocatib Setback, and Updated Analyst Forecasts (Dec. 22, 2025)

Insmed Incorporated (NASDAQ: INSM) is ending 2025 with two headlines pulling the stock in opposite directions: fresh visibility from joining the Nasdaq‑100 Index and fresh volatility after a clinical disappointment for a key expansion effort. As of Monday, December 22, 2025 (17:56 UTC), INSM traded at $177.86, up about $3.02 (~1.7%) on the day, after swinging sharply in recent sessions. Below is what’s moving Insmed stock now, what Wall Street is forecasting after the latest developments, and the pipeline and financial checkpoints investors are watching into 2026. What’s driving Insmed stock on Dec. 22, 2025 1) Insmed officially joins the
22 December 2025
····
1 … 1,313 1,314 1,315 1,316 1,317 … 2,709

Stock Market Today

ST Engineering stock price drops 2% to S$9.71 as drone-autonomy tie-up grabs attention

ST Engineering stock price drops 2% to S$9.71 as drone-autonomy tie-up grabs attention

7 February 2026
ST Engineering shares fell 1.9% to S$9.71 Friday, outpacing the Singapore market’s 0.8% drop amid a tech-led selloff. The company signed a deal with Shield AI at the Singapore Airshow to integrate autonomy software into its unmanned platforms and unveiled a small drone capable of carrying explosives. About 6.9 million shares traded as investors await full-year results on Feb. 27.
Go toTop